Atinvicitinib
Atinvicitinib is a kind of pyrazole compound. Atinvicitinib has the potential for the research of atopic dermatitis (extracted from patent WO2021123094A1) [1].
Product Specifications
CAS Number
2169273-59-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/atinvicitinib.html
Concentration
10mM
Purity
98.03
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#C[C@@H]1[C@](N2N=C(C(C(N)=O)=C2)NC3=CC(F)=NC(OC)=C3)([H])COCC1
Molecular Formula
C16H17FN6O3
Molecular Weight
360.34
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Mohamad Morsey, et al. Bispecific caninized antibodies and bispecific binding partners for treating atopic dermatitis. Patent WO2021123094A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD35 / CR1 (E11), CF640R conjugate, 0.1mg/mL
TAG-72 / CA72.4 (B72.3), CF640R conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF568 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF488A conjugate, 0.1mg/mL
HCG-beta (HCGb/54), CF740 conjugate, 0.1mg/mL
